Variable | Groups | AUC | Cut-off | P-value | Sensitivity (%) | Specificity (%) | Comparison of AUC | |
---|---|---|---|---|---|---|---|---|
Groups | P-value | |||||||
Benign vs. malignant | CA125 + NLR | 0.9540 | 0.3679 | < 0.0001 | 90.63 | 99.35 | a vs. b | 0.1785 |
CA125 + PLR | 0.9692 | 0.4404 | < 0.0001 | 90.63 | 98.71 | b vs. c | 0.1217 | |
CA125 + NLR + PLR | 0.9793 | 0.2401 | < 0.0001 | 93.75 | 96.77 | a vs. c | 0.0491 | |
Benign vs. borderline | CA125 + NLR | 0.8856 | 0.3132 | < 0.0001 | 71.43 | 93.55 | a vs. b | 0.0932 |
CA125 + PLR | 0.9144 | 0.2715 | < 0.0001 | 80.95 | 91.61 | b vs. c | 0.1981 | |
CA125 + NLR + PLR | 0.9287 | 0.2699 | < 0.0001 | 85.71 | 90.97 | a vs. c | 0.0037 | |
Borderline vs. malignant | CA125 + NLR | 0.7676 | 0.4350 | < 0.0001 | 70.31 | 79.37 | a vs. b | 0.6527 |
CA125 + PLR | 0.7584 | 0.4406 | < 0.0001 | 73.44 | 73.02 | b vs. c | 0.5866 | |
CA125 + NLR + PLR | 0.7617 | 0.4129 | < 0.0001 | 78.13 | 68.25 | a vs. c | 0.7360 |